Effect of glucosphingolipid synthesis inhibitor (PPMP and PDMP) treatment on Tetrahymena pyriformis

Data on the evolution of the signaling system

Péter Kovács, Miklós Pintér, G. Csaba

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) are structural analogues of ceramide; inhibiting UDP-glucose: ceramide glucosyltransferase. After treatment with these synthetic ceramide analogues the expression of glucosphingolipid decreases, while ceramide and sphingomyelin levels increase in the cells of higher eukaryotes. In the unicellular Tetrahymena pyriformis, treatment with PDMP (10-20 μM) and PPMP (40-80 μM) influenced the synthesis of galactose, glucosamine and mannosecontaining lipids. On the whole the amount of these lipids was reduced, but new galactose and glucosaminecontaining lipids appeared (the exact structures of these lipids were not characterized). Incorporation of 32P into phosphatidylethanolamine (PE) and phosphatidic acid (PA) was decreased significantly; however the amount of inositol phospholipids were increased. The incorporation of 3H-serine into phosphatidylserine was abolished, but incorporation into sphingomyelin and ceramide was increased. The cytoskeletal elements (silver line system) were disturbed on the basis of scanning electron microscopic pictures. The TRITC-Con A binding and the morphology of the cells were influenced as revealed by confocal laser scanning microscopic analyses. In contrast to higher eukaryotes, in Tetrahymena the shorter fatty acyl chain variant (PDMP) proved to be more effective in each of the examined parameters, while the longer chain variants (PPMP) had milder activity.

Original languageEnglish
Pages (from-to)269-280
Number of pages12
JournalCell Biochemistry and Function
Volume18
Issue number4
DOIs
Publication statusPublished - 2000

Fingerprint

Tetrahymena pyriformis
Ceramides
Lipids
Sphingomyelins
ceramide glucosyltransferase
Eukaryota
Galactose
Scanning
Tetrahymena
Phosphatidic Acids
Glucosamine
Phosphatidylserines
Phosphatidylinositols
Silver
Serine
Lasers
Electrons
RV 538
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol

Keywords

  • Ceramide
  • Glucosphingolipids
  • Glycerophospholipids
  • Tetrahymena

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology

Cite this

Effect of glucosphingolipid synthesis inhibitor (PPMP and PDMP) treatment on Tetrahymena pyriformis : Data on the evolution of the signaling system. / Kovács, Péter; Pintér, Miklós; Csaba, G.

In: Cell Biochemistry and Function, Vol. 18, No. 4, 2000, p. 269-280.

Research output: Contribution to journalArticle

@article{cb0883de70d6412180adf5a84be2e286,
title = "Effect of glucosphingolipid synthesis inhibitor (PPMP and PDMP) treatment on Tetrahymena pyriformis: Data on the evolution of the signaling system",
abstract = "1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) are structural analogues of ceramide; inhibiting UDP-glucose: ceramide glucosyltransferase. After treatment with these synthetic ceramide analogues the expression of glucosphingolipid decreases, while ceramide and sphingomyelin levels increase in the cells of higher eukaryotes. In the unicellular Tetrahymena pyriformis, treatment with PDMP (10-20 μM) and PPMP (40-80 μM) influenced the synthesis of galactose, glucosamine and mannosecontaining lipids. On the whole the amount of these lipids was reduced, but new galactose and glucosaminecontaining lipids appeared (the exact structures of these lipids were not characterized). Incorporation of 32P into phosphatidylethanolamine (PE) and phosphatidic acid (PA) was decreased significantly; however the amount of inositol phospholipids were increased. The incorporation of 3H-serine into phosphatidylserine was abolished, but incorporation into sphingomyelin and ceramide was increased. The cytoskeletal elements (silver line system) were disturbed on the basis of scanning electron microscopic pictures. The TRITC-Con A binding and the morphology of the cells were influenced as revealed by confocal laser scanning microscopic analyses. In contrast to higher eukaryotes, in Tetrahymena the shorter fatty acyl chain variant (PDMP) proved to be more effective in each of the examined parameters, while the longer chain variants (PPMP) had milder activity.",
keywords = "Ceramide, Glucosphingolipids, Glycerophospholipids, Tetrahymena",
author = "P{\'e}ter Kov{\'a}cs and Mikl{\'o}s Pint{\'e}r and G. Csaba",
year = "2000",
doi = "10.1002/1099-0844(200012)18:4<269::AID-CBF883>3.0.CO;2-H",
language = "English",
volume = "18",
pages = "269--280",
journal = "Cell Biochemistry and Function",
issn = "0263-6484",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Effect of glucosphingolipid synthesis inhibitor (PPMP and PDMP) treatment on Tetrahymena pyriformis

T2 - Data on the evolution of the signaling system

AU - Kovács, Péter

AU - Pintér, Miklós

AU - Csaba, G.

PY - 2000

Y1 - 2000

N2 - 1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) are structural analogues of ceramide; inhibiting UDP-glucose: ceramide glucosyltransferase. After treatment with these synthetic ceramide analogues the expression of glucosphingolipid decreases, while ceramide and sphingomyelin levels increase in the cells of higher eukaryotes. In the unicellular Tetrahymena pyriformis, treatment with PDMP (10-20 μM) and PPMP (40-80 μM) influenced the synthesis of galactose, glucosamine and mannosecontaining lipids. On the whole the amount of these lipids was reduced, but new galactose and glucosaminecontaining lipids appeared (the exact structures of these lipids were not characterized). Incorporation of 32P into phosphatidylethanolamine (PE) and phosphatidic acid (PA) was decreased significantly; however the amount of inositol phospholipids were increased. The incorporation of 3H-serine into phosphatidylserine was abolished, but incorporation into sphingomyelin and ceramide was increased. The cytoskeletal elements (silver line system) were disturbed on the basis of scanning electron microscopic pictures. The TRITC-Con A binding and the morphology of the cells were influenced as revealed by confocal laser scanning microscopic analyses. In contrast to higher eukaryotes, in Tetrahymena the shorter fatty acyl chain variant (PDMP) proved to be more effective in each of the examined parameters, while the longer chain variants (PPMP) had milder activity.

AB - 1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) are structural analogues of ceramide; inhibiting UDP-glucose: ceramide glucosyltransferase. After treatment with these synthetic ceramide analogues the expression of glucosphingolipid decreases, while ceramide and sphingomyelin levels increase in the cells of higher eukaryotes. In the unicellular Tetrahymena pyriformis, treatment with PDMP (10-20 μM) and PPMP (40-80 μM) influenced the synthesis of galactose, glucosamine and mannosecontaining lipids. On the whole the amount of these lipids was reduced, but new galactose and glucosaminecontaining lipids appeared (the exact structures of these lipids were not characterized). Incorporation of 32P into phosphatidylethanolamine (PE) and phosphatidic acid (PA) was decreased significantly; however the amount of inositol phospholipids were increased. The incorporation of 3H-serine into phosphatidylserine was abolished, but incorporation into sphingomyelin and ceramide was increased. The cytoskeletal elements (silver line system) were disturbed on the basis of scanning electron microscopic pictures. The TRITC-Con A binding and the morphology of the cells were influenced as revealed by confocal laser scanning microscopic analyses. In contrast to higher eukaryotes, in Tetrahymena the shorter fatty acyl chain variant (PDMP) proved to be more effective in each of the examined parameters, while the longer chain variants (PPMP) had milder activity.

KW - Ceramide

KW - Glucosphingolipids

KW - Glycerophospholipids

KW - Tetrahymena

UR - http://www.scopus.com/inward/record.url?scp=0034490583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034490583&partnerID=8YFLogxK

U2 - 10.1002/1099-0844(200012)18:4<269::AID-CBF883>3.0.CO;2-H

DO - 10.1002/1099-0844(200012)18:4<269::AID-CBF883>3.0.CO;2-H

M3 - Article

VL - 18

SP - 269

EP - 280

JO - Cell Biochemistry and Function

JF - Cell Biochemistry and Function

SN - 0263-6484

IS - 4

ER -